IL-22 is produced by CD3-c-Kit+ cells in skin lesions of patients with psoriasis and AD, and c-Kit + FcεRI+ mast cells are the major cellular source of IL-22 in AD patients [53]. This evidence concerns the gene KIT and psoriasis.